ARTICLE | Company News
Expanded label for Guilford's Gliadel
February 26, 2003 8:00 AM UTC
The FDA approved GLFD's Gliadel wafer carmustine implant as an adjunct to surgery and radiation in newly diagnosed patients with high-grade malignant glioma. The compound already is approved to treat ...